XML 59 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Aug. 06, 2020
Oct. 26, 2021
Oct. 21, 2021
Sep. 29, 2020
Sep. 24, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 29, 2021
Aug. 12, 2021
Dec. 29, 2020
Stockholders’ Equity (Details) [Line Items]                    
Description of shares of common stock       Annual Meeting of our Company held on September 29, 2020, stockholders approved a proposal to increase the number of authorized shares of our common stock to 25,000,000 shares. Accordingly, on November 5, 2020, we filed an amendment to the Neonode Inc. Restated Certificate of Incorporation, as amended (our “Certificate of Incorporation”), with the Secretary of State of the State of Delaware to increase the number of authorized shares of our common stock to 25,000,000 shares.            
Shares issued               14,735 12,830  
Net proceeds (in Dollars)   $ 13,100,000                
Number of shares     1,808,000              
Shares price (in Dollars per share)     $ 7.75              
Number of warrants exercised             325,000      
Dividends at the rate             5.00%      
Total dividends received (in Dollars)             $ 33,000      
Common Stock [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Shares issued                   37,288
Aggregate shares           235,722        
Net proceeds (in Dollars)           $ 1,984,000        
Commissions amount (in Dollars)           $ 66,000        
Series C-1 Preferred Stock and Series C-2 Preferred Stock [Member] | Neonode [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Shares of Neonode common stock       684,378 684,378          
Series C-1 Preferred Stock and Series C-2 Preferred Stock [Member] | Private Placement [Member]                    
Stockholders’ Equity (Details) [Line Items]                    
Description of shares of common stock On August 6, 2020, in connection with the closing of the Private Placement, the Company designated (i) 365 shares of its authorized and unissued preferred stock as Series C-1 Preferred Stock by filing a Series C-1 Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware and (ii) 4,084 shares of its authorized and unissued preferred stock as Series C-2 Preferred Stock by filing a Series C-2 Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware.